G5087110 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from G5087110. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In G5087110 Today - Breaking & Trending Today

Analysts Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average […] ....

United States , Philipl Johnson , Patricia Carr , Royal Bank , Jazz Pharmaceuticals Stock , Jazz Pharmaceuticals Company Profile , Jazz Pharmaceuticals , Exchange Traded Concepts , Analyst Recommendations For Jazz Pharmaceuticals , Commonwealth Equity Services , Cantor Fitzgerald , Needham Company , Hedge Funds Weigh In On Jazz Pharmaceuticals , Securities Exchange Commission , Sg Americas Securities , News Ratings For Jazz Pharmaceuticals Daily , Asset Management One Co , Get Free Report , Marketbeat Ratings , Exchange Commission , Traded Concepts , Management One , Equity Services , Fourth Swedish National Pension Fund , Get Free , Jazz Pharmaceuticals Daily ,

StockNews.com Lowers Jazz Pharmaceuticals (NASDAQ:JAZZ) to Buy

StockNews.com downgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) from a strong-buy rating to a buy rating in a report issued on Thursday morning. Other analysts have also issued reports about the stock. Cantor Fitzgerald reiterated an overweight rating and issued a $180.00 price target on shares of Jazz Pharmaceuticals in a research report […] ....

United States , Philipl Johnson , Stifel Nicolaus , Patricia Carr , Piper Sandler , Jazz Pharmaceuticals Stock Performance , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals , Sg Americas Securities , Insider Activity At Jazz Pharmaceuticals , Cantor Fitzgerald , Commonwealth Equity Services , Asset Management One Co , Analyst Recommendations For Jazz Pharmaceuticals , Pinnacle Associates Ltd , Hedge Funds Weigh In On Jazz Pharmaceuticals , Jazz Pharmaceuticals Company Profile , Free Report , Moderate Buy , Get Free Report , Management One , Equity Services , Fourth Swedish National Pension Fund , Pinnacle Associates , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) PT Lowered to $200.00

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its price target cut by Barclays from $230.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the specialty pharmaceutical company’s stock. Barclays‘s price target would indicate a potential upside of 81.80% from the stock’s […] ....

United States , Patricia Carr , Piper Sandler , Philipl Johnson , Dekabank Deutsche Girozentrale , Baupost Group , Institutional Investors Weigh In On Jazz Pharmaceuticals , Analyst Recommendations For Jazz Pharmaceuticals , Jpmorgan Chase Co , Jazz Pharmaceuticals , International Assets Investment Management , Kovack Advisors Inc , Royal Bank , Jazz Pharmaceuticals Company Profile , Securities Exchange Commission , Cantor Fitzgerald , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Stock , Desjardins Global Asset Management Inc , Get Free Report , Truist Financial , Exchange Commission , Assets Investment Management , Global Asset Management , Bank Deutsche Girozentrale , Jazz Pharmaceuticals Daily ,

Todd Asset Management LLC Sells 4,977 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Todd Asset Management LLC cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 170,233 shares of the specialty pharmaceutical company’s stock after selling 4,977 shares during the period. Todd […] ....

United States , Philipl Johnson , Stifel Nicolaus , Patricia Carr , Piper Sandler , Todd Asset Management , Exchange Commission , Quarter For Jazz Pharmaceuticals , Jazz Pharmaceuticals Price Performance , Securities Exchange Commission , Cantor Fitzgerald , Headlands Technologies , Jazz Pharmaceuticals , Royal Bank , News Ratings For Jazz Pharmaceuticals Daily , Covestor Ltd , Free Report , Asset Management , Wealth Management , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $195.08 Consensus Price Target from Analysts

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 1 year price […] ....

United States , Patricia Carr , Philipl Johnson , Piper Sandler , Covestor Ltd , Rise Advisors , Jazz Pharmaceuticals , Institutional Trading Of Jazz Pharmaceuticals , Jpmorgan Chase Co , Assetmark Inc , Securities Exchange Commission , Cape Investment Advisory Inc , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Company Profile , Jazz Pharmaceuticals Price Performance , Analyst Recommendations For Jazz Pharmaceuticals , Get Free Report , Marketbeat Ratings , Exchange Commission , Investment Advisory , Spire Wealth Management , Wealth Management , Get Free , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,